InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the complete record of transactions filed by Odegard Valerie, Chief Executive Officer. Officer active across 1 company, notably Silverback Therapeutics, Inc.. Cumulatively, 2 filings have been recorded. History available since 1 February 2022. The latest transaction was disclosed on 2 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Odegard Valerie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
45,233 shares0Common StockSEC:0001209191-22-027158:0
16,406 shares0Common StockSEC:0001209191-22-006434:0
2 of 2 declarations
About Odegard Valerie
Valerie Odegard is the CEO and Chief Strategy Officer at Silverback Therapeutics, Inc. She is responsible for the strategic leadership of the company, overseeing operations and growth initiatives. Her leadership is crucial for Silverback's success in the biopharmaceutical sector.
